Ligand validation:6JY3

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 6JY3 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JY3_CDL_B_301	33%	24%	0.163	0.908	1.53	1.57	5	14	0	0	64%	0.64
6JY3_CDL_A_606	31%	35%	0.218	0.9	0.98	1.55	4	15	8	0	94%	0.94
6JY3_CDL_C_305	12%	35%	0.266	0.817	1.19	1.38	6	13	4	0	87%	0.87
7COH_CDL_A_521	33%	72%	0.212	0.901	0.46	0.6	-	2	6	0	94%	0.94
6JUW_CDL_C_307	31%	25%	0.195	0.862	1.4	1.66	14	17	15	0	100%	1
6JY4_CDL_B_301	29%	25%	0.183	0.904	1.42	1.6	4	13	2	0	64%	0.64
7D5X_CDL_C_308	27%	29%	0.184	0.86	1.27	1.57	10	12	11	0	85%	0.85
7CP5_CDL_P_304	24%	42%	0.181	0.878	1.22	1.05	7	4	4	0	61%	0.61
5Y5S_CDL_M_415	41%	34%	0.128	0.953	1.32	1.27	3	3	1	0	39%	0.39
2GNU_CDL_M_1309	38%	22%	0.122	0.984	1.77	1.5	3	3	0	0	10%	10
3ZDQ_CDL_A_1721	37%	64%	0.215	0.943	0.72	0.65	4	4	0	1	84%	0.42
7A0W_CDL_A_501	32%	37%	0.15	0.908	1.28	1.2	4	6	2	0	52%	0.52

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.